- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Severe Chronic Plaque Psoriasis (CPP)
- Meeting Date: March 2021
- Public Summary Document (PSD) March 2021 PBAC Meeting - (PDF 744KB)
- Public Summary Document (PSD) March 2021 PBAC Meeting - (Word 55KB)
Guselkumab – March 2021
Guselkumab: Injection 100 mg in 1 mL single use pre-filled pen; Tremfya®
Last updated
2 July 2021